CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Mometasone furoate and formoterol

Last Updated: February 16, 2011
Result type: Reports
Project Number: SR0225-000
Product Line: Reimbursement Review

Generic Name: Mometasone furoate and formoterol

Brand Name: Zenhale (inhalation aerosol)

Manufacturer: Merck Canada

Therapeutic Area: Asthma

Indications: Asthma maintenance (adults, children 12 or older)

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: September 28, 2011

Recommendation Type: Do not list